Clinical Trials Logo

Clinical Trial Summary

Dexmedetomidine is an α2 receptor agonist with sedative and analgesic properties. In previous reports, dexmedetomidine improves smoothness of postoperative recovery and reduces intraoperatory imflammatory responses. As patients receiving breast surgeries are especially vulnerable to postoperative nausea/ vomiting, the dosage of narcotics and associated complications were concerned for not only comfortness but also postoperative oral intake and discharge. The invetigators aimed to compare the effects of dexmedetomidine infusion versus placebo on postoperative narcotics requirement, complications, and oral intake.


Clinical Trial Description

Dexmedetomidine is an α2 receptor agonist with sedative and analgesic properties. In previous reports, dexmedetomidine improves smoothness of postoperative recovery and reduces intraoperatory imflammatory responses. As patients receiving breast surgeries are especially vulnerable to postoperative nausea/ vomiting, the dosage of narcotics and associated complications were concerned for not only comfortness but also postoperative oral intake and discharge. The invetigators aimed to compare the effects of dexmedetomidine infusion versus placebo on postoperative narcotics requirement, complications, and oral intake. The participantss under general anesthesia and aged from 30 to 65 years old will be enrolled. All subjects were randomized into the dexmedetomidine or placebo group. They received placebo (group P, n = 30) or dexmedetomidine (loading dose of 1 μg kg-1 followed by 0.5 μg kg-1 h-1) (group D, n = 30) to the end of surgery. Data collected included intraoperative and postoperative opioid consumption. Postoperative questionare including PONV, Pain intensity, I-FEED questionnaire. Prospective analysis will be performed on the prospectively collected data. We expected to examine if intraoperative dexmedetomidine decreases the postoperative opioid consumption and associated complications, and enhances the gastrointestinal recovery and oral intake with narcotic-sparing effect. ;


Study Design


Related Conditions & MeSH terms


NCT number NCT04454515
Study type Interventional
Source National Taiwan University Hospital
Contact Ya-Jung Cheng, MD,PhD
Phone 23220322
Email chengyj@ntu.edu.tw
Status Recruiting
Phase N/A
Start date April 20, 2021
Completion date July 1, 2025

See also
  Status Clinical Trial Phase
Completed NCT04090099 - Bilateral Erector Spina Block Versus Parasternal Block in Adult Heart Surgery N/A
Completed NCT06002867 - Serratus Anterior Plan Block and Postoperative Pain in Patients Who Underwent Minimally Invasive Cardiac Surgery N/A
Completed NCT02712749 - Use of Binaural Beat Premedication in Elderly Submitted to Major Orthopedic Surgery N/A
Completed NCT00199303 - Efficacy of Pre- and Post-Operative Oral Dextromethorphan N/A